State University of New York at Buffalo
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, State University of New York at Buffalo sits in the top decile of US sponsors by registered trial count (#135 of 15,742 sponsors by registered trial count).
State University of New York at Buffalo: 243 sponsored US clinical trials, 52 recruiting.
State University of New York at Buffalo sponsors 243 registered US clinical trials on ClinicalTrials.gov, 52 of them currently recruiting, and 156 completed. 19 of these trials are in Phase 3-4 (later-stage) and 26 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Multiple Sclerosis, with 4 trials.
Top-decile sponsor footprint
State University of New York at Buffalo ranks in the top decile of sponsors by registered trial count (#135 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
156 of 172 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
243 total, page 5 of 5
24 Hour Ambulatory Cardiac Oxygen Consumption
NCT05170061
Heart Rate Response to Atropine Doses Less Than 0.1mg IV to Anesthetized Infants
NCT01819064
Habituation to Food as a Risk Factor for Pediatric Obesity
NCT02229552
Comparing the Laryngoscopy View Using Miller and Macintosh Laryngoscopy Blades in Infants Under Two Years of Age
NCT01717872
Price Changes and Nutrient Profiling Among Adult Grocery Shoppers
NCT02376530
Therapeutic Alliances in Alcoholism Treatment
NCT01689103
Intravenous Magnesium Infusion in Patients Undergoing Cardioversion of Atrial Fibrillation Trial
NCT01597557
Buprenorphine and Methadone for Opioid-dependent Chronic Back Pain Patients
NCT01559454
The ChAMP (Chondral Lesions And Meniscus Procedures) Trial
NCT01527201
Effects of Dalfampridine on Cognition in Multiple Sclerosis
NCT02006160
Gender Difference in Response to Caffeine in Children and Adolescents
NCT02119416
Gabapentin's Effects on Insomnia in Patients With Recent Concussion
NCT01421264
Technology-assisted Case Management in Adults With Type 2 Diabetes
NCT01373489
Prevalence of Decreased Corneal Sensation in Patients With Chronic Inflammatory Demyelinating Polyneuropathy
NCT01379833
Price Changes and Hypothetical Food Purchases in Adult Grocery Shoppers
NCT01619787
Self Administered Cognitive Behavior Therapy for Irritable Bowel Syndrome
NCT00738920
A Randomized Trial of Interventions for Teenage Drivers With Attention Deficit Hyperactivity Disorder (ADHD)
NCT01322646
Prospective Randomized Endovascular Therapy in Multiple Sclerosis - PREMiSE
NCT01450072
Hypogonadism in Young Men With Type 2 Diabetes
NCT01155518
Discordance of Obesity in Adolescent Sibilngs
NCT02376439
Identifying Multiple Mechanisms of Change in Alcoholism Treatment
NCT01168960
Study of Lisdexamfetamine Sulfate to Treat Cognitive Dysfunction in Multiple Sclerosis
NCT01615887
Translating Habituation Research to Interventions for Pediatric Obesity
NCT01208870
Buprenorphine and Methadone for Opioid Dependent Chronic Pain Patients
NCT00879996
Food Reinforcement, Weight Status, and Energy Density
NCT03981172
Telephone Delivered Behavioral Skills Intervention for Blacks With T2DM
NCT00929838
Cardioprotective Benefits of Carvedilol-CR or Valsartan Added to Lisinopril
NCT00657241
Treating Pre-School Children at Risk for Overweight in the Primary Care Setting
NCT01029834
Metabolic Effects of Olanzapine in Healthy Males
NCT01496183
Cost-effectiveness of Family Based Pediatric Obesity Treatment
NCT00717132
Buprenorphine as a Treatment in Opiate Dependent Pain Patients
NCT00552578
Affect Regulation Training for Pregnant Smokers
NCT01163864
Facilitating Aftercare for Alcohol Detox Patients
NCT00513708
Snack Food Reinforcement in Obese and Non-obese Women
NCT00837694
"Lidocaine 4% Cream (LMX4) vs Placebo for Pain Due to Lumbar Puncture in Infants 0-60 Days of Age."
NCT00533468
Impact of Strattera and Behavior Therapy on the Home and School Functioning of Children With ADHD
NCT00918567
Effect of Changing Sedentary Behavior in Youth
NCT00962247
Effect of Interferon Beta-1a (Avonex®) on Changes of Non-conventional MRI Measures in Patients With MS
NCT00463710
Prospective Registry of Anterior Cruciate Ligament Reconstructions
NCT04135950
Prediction of ARrhythmic Events With Positron Emission Tomography
NCT01400334
Effect of Improved Oral Hygiene to Prevent Pneumonia in Hospitalized Patients
NCT00123123
A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic's Disease)
NCT00304291
Effects of Infant Egg Consumption on Child Health and Cognition Development
NCT04345185
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 11 |
| Phase 2 | 15 |
| Phase 3 | 7 |
| Phase 4 | 12 |
What is open in the State University of New York at Buffalo pipeline
52 recruiting of 243 indexed (21% open); 156 completed (64%).
Phase mix: 19 late (III/IV) vs 26 early (I/II) (balanced across stages).
Top condition: Multiple Sclerosis (4 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
State University of New York at Buffalo: open-pipeline peers nationwide
Peers matched on 243 registered trials and 21% open enrollment, not the therapeutic-area sidebar.
State University of New York at Buffalo sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 243 trials (± recruiting share)
- Shire · 245 trials · 0% recruiting
- University of Cincinnati · 245 trials · 14% recruiting
- University of Massachusetts, Worcester · 240 trials · 13% recruiting
- Incyte Corporation · 239 trials · 15% recruiting
Sponsors near 21% open enrollment (± trial volume)
- Axsome Therapeutics · 21% recruiting · 28 trials
- GOG Foundation · 21% recruiting · 14 trials
- Kettering Health Network · 21% recruiting · 14 trials
- LifeBridge Health · 21% recruiting · 14 trials
Related
What to do with this State University of New York at Buffalo page
243 registered trials is a research-attention snapshot, not an endorsement of State University of New York at Buffalo or any single study.
- 52 of State University of New York at Buffalo's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Multiple Sclerosis is the condition State University of New York at Buffalo studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Multiple Sclerosis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. State University of New York at Buffalo pipeline card: 243 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.